Start here: small but suggestive
This mechanism rests on a limited evidence base, mainly a single sizeable case series, not repeated large studies. That places it firmly in the interesting-hypothesis column. The reason it earns a page is that it dovetails with independent long COVID work pointing at low serotonin, so two separate threads may be describing the same biology.
Read it as a lead worth following, not a settled explanation. The honest label is low certainty with a coherent mechanism, which is different from proven and also different from fringe.
low certaintysingle small cohortcoherent with serotonin biology
What platelets have to do with it
Most of the body's serotonin outside the brain is not floating free; it is packed into tiny storage granules inside platelets and released when needed. In a storage pool deficiency, those granules are depleted, so the platelets carry and release less serotonin than normal.
In a study of POTS patients investigated for easy bruising and bleeding, most were found to have this platelet storage problem, and their platelet serotonin levels were significantly lower than in controls. The authors were careful: the association does not establish that it causes POTS.
Why serotonin matters for standing
Serotonin is not just a mood molecule. In the body and brainstem it helps regulate blood vessel tone, heart rate, and the autonomic reflexes that keep blood pressure steady when you stand. A shortage could plausibly blunt those reflexes and contribute to the orthostatic problem.
This is mechanism-level reasoning rather than proof in patients. It explains why a serotonin deficit is a credible contributor to POTS symptoms, and why it sits alongside, not instead of, the low blood volume and autonomic explanations on the other mechanism pages.
The long COVID connection
Separately from the POTS work, research into post-viral illness has reported that the inflammation of infection can lower circulating serotonin, through reduced absorption of its dietary precursor and changes in platelet handling, with knock-on effects on vagal signalling and possibly cognition.
If that holds, low serotonin becomes a thread that could tie together orthostatic symptoms, fatigue, and brain fog in long COVID rather than explaining only one. The POTS platelet finding and the post-viral serotonin finding may be two windows onto the same process, which is what makes this more than a curiosity.
links to a broader, still-emerging serotonin hypothesis
What it does and does not justify
A tempting jump is from low serotonin to taking an SSRI, which raises serotonin signalling. That jump is not warranted by this evidence. The biology is more complex than more-is-better, SSRIs have mixed and unproven results in this setting, and self-medicating on a mechanistic hunch can backfire.
What the finding justifies is interest and further study, not a specific treatment you should request. Any use of serotonergic drugs here belongs to a clinician weighing your whole picture, and is discussed on the antidepressant page with its own thin evidence base.
How to weigh it
Treat this as a promising fragment. It is reproducible enough to take seriously, small enough that it could shrink or grow with the next study, and connected enough to the wider serotonin work to be more than noise. That is a fair and unglamorous summary.
If you see it presented as the cause of POTS or long COVID, that overstates a single-cohort association. If you see it dismissed, that ignores a coherent and testable lead. The useful stance is curiosity with a clear view of how thin the floor still is.
What we don't know
Honest about the edges of the evidence. These are open questions, not settled answers.
- Whether low platelet serotonin causes POTS symptoms or simply accompanies them.
- How common the platelet storage deficit is across unselected POTS and long COVID patients.
- Whether the POTS platelet finding and the post-viral serotonin findings share one mechanism.
- Whether correcting serotonin changes orthostatic symptoms at all.
- How serotonin status interacts with blood volume and autonomic drivers.
- Why only some patients show the storage-pool deficiency.
What this means for you
This is an early, coherent lead linking POTS to a serotonin deficit that wider long COVID research is also circling. It is reasonable to find it interesting and to watch where it goes, while knowing the evidence is a single small cohort, not an established cause.
It does not justify reaching for an SSRI on your own, because the biology is not more-is-better and the drug evidence is mixed. Keep it as one testable piece of the orthostatic puzzle and let a clinician weigh any serotonergic treatment in the context of your whole picture.
References
Each reference links to the source on PubMed, PMC, or the publisher.